Cargando…
Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection
OBJECTIVE: Faecal microbiota transplant (FMT) effectively treats recurrent Clostridioides difficile infection (rCDI), but its mechanisms of action remain poorly defined. Certain bile acids affect C. difficile germination or vegetative growth. We hypothesised that loss of gut microbiota-derived bile...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839797/ https://www.ncbi.nlm.nih.gov/pubmed/30816855 http://dx.doi.org/10.1136/gutjnl-2018-317842 |
_version_ | 1783467491401400320 |
---|---|
author | Mullish, Benjamin H McDonald, Julie A K Pechlivanis, Alexandros Allegretti, Jessica R Kao, Dina Barker, Grace F Kapila, Diya Petrof, Elaine O Joyce, Susan A Gahan, Cormac G M Glegola-Madejska, Izabela Williams, Horace R T Holmes, Elaine Clarke, Thomas B Thursz, Mark R Marchesi, Julian R |
author_facet | Mullish, Benjamin H McDonald, Julie A K Pechlivanis, Alexandros Allegretti, Jessica R Kao, Dina Barker, Grace F Kapila, Diya Petrof, Elaine O Joyce, Susan A Gahan, Cormac G M Glegola-Madejska, Izabela Williams, Horace R T Holmes, Elaine Clarke, Thomas B Thursz, Mark R Marchesi, Julian R |
author_sort | Mullish, Benjamin H |
collection | PubMed |
description | OBJECTIVE: Faecal microbiota transplant (FMT) effectively treats recurrent Clostridioides difficile infection (rCDI), but its mechanisms of action remain poorly defined. Certain bile acids affect C. difficile germination or vegetative growth. We hypothesised that loss of gut microbiota-derived bile salt hydrolases (BSHs) predisposes to CDI by perturbing gut bile metabolism, and that BSH restitution is a key mediator of FMT’s efficacy in treating the condition. DESIGN: Using stool collected from patients and donors pre-FMT/post-FMT for rCDI, we performed 16S rRNA gene sequencing, ultra performance liquid chromatography mass spectrometry (UPLC-MS) bile acid profiling, BSH activity measurement, and qPCR of bsh/baiCD genes involved in bile metabolism. Human data were validated in C. difficile batch cultures and a C57BL/6 mouse model of rCDI. RESULTS: From metataxonomics, pre-FMT stool demonstrated a reduced proportion of BSH-producing bacterial species compared with donors/post-FMT. Pre-FMT stool was enriched in taurocholic acid (TCA, a potent C. difficile germinant); TCA levels negatively correlated with key bacterial genera containing BSH-producing organisms. Post-FMT samples demonstrated recovered BSH activity and bsh/baiCD gene copy number compared with pretreatment (p<0.05). In batch cultures, supernatant from engineered bsh-expressing E. coli and naturally BSH-producing organisms (Bacteroides ovatus, Collinsella aerofaciens, Bacteroides vulgatus and Blautia obeum) reduced TCA-mediated C. difficile germination relative to culture supernatant of wild-type (BSH-negative) E. coli. C. difficile total viable counts were ~70% reduced in an rCDI mouse model after administration of E. coli expressing highly active BSH relative to mice administered BSH-negative E. coli (p<0.05). CONCLUSION: Restoration of gut BSH functionality contributes to the efficacy of FMT in treating rCDI. |
format | Online Article Text |
id | pubmed-6839797 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-68397972019-11-12 Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection Mullish, Benjamin H McDonald, Julie A K Pechlivanis, Alexandros Allegretti, Jessica R Kao, Dina Barker, Grace F Kapila, Diya Petrof, Elaine O Joyce, Susan A Gahan, Cormac G M Glegola-Madejska, Izabela Williams, Horace R T Holmes, Elaine Clarke, Thomas B Thursz, Mark R Marchesi, Julian R Gut Gut Microbiota OBJECTIVE: Faecal microbiota transplant (FMT) effectively treats recurrent Clostridioides difficile infection (rCDI), but its mechanisms of action remain poorly defined. Certain bile acids affect C. difficile germination or vegetative growth. We hypothesised that loss of gut microbiota-derived bile salt hydrolases (BSHs) predisposes to CDI by perturbing gut bile metabolism, and that BSH restitution is a key mediator of FMT’s efficacy in treating the condition. DESIGN: Using stool collected from patients and donors pre-FMT/post-FMT for rCDI, we performed 16S rRNA gene sequencing, ultra performance liquid chromatography mass spectrometry (UPLC-MS) bile acid profiling, BSH activity measurement, and qPCR of bsh/baiCD genes involved in bile metabolism. Human data were validated in C. difficile batch cultures and a C57BL/6 mouse model of rCDI. RESULTS: From metataxonomics, pre-FMT stool demonstrated a reduced proportion of BSH-producing bacterial species compared with donors/post-FMT. Pre-FMT stool was enriched in taurocholic acid (TCA, a potent C. difficile germinant); TCA levels negatively correlated with key bacterial genera containing BSH-producing organisms. Post-FMT samples demonstrated recovered BSH activity and bsh/baiCD gene copy number compared with pretreatment (p<0.05). In batch cultures, supernatant from engineered bsh-expressing E. coli and naturally BSH-producing organisms (Bacteroides ovatus, Collinsella aerofaciens, Bacteroides vulgatus and Blautia obeum) reduced TCA-mediated C. difficile germination relative to culture supernatant of wild-type (BSH-negative) E. coli. C. difficile total viable counts were ~70% reduced in an rCDI mouse model after administration of E. coli expressing highly active BSH relative to mice administered BSH-negative E. coli (p<0.05). CONCLUSION: Restoration of gut BSH functionality contributes to the efficacy of FMT in treating rCDI. BMJ Publishing Group 2019-10 2019-02-11 /pmc/articles/PMC6839797/ /pubmed/30816855 http://dx.doi.org/10.1136/gutjnl-2018-317842 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Gut Microbiota Mullish, Benjamin H McDonald, Julie A K Pechlivanis, Alexandros Allegretti, Jessica R Kao, Dina Barker, Grace F Kapila, Diya Petrof, Elaine O Joyce, Susan A Gahan, Cormac G M Glegola-Madejska, Izabela Williams, Horace R T Holmes, Elaine Clarke, Thomas B Thursz, Mark R Marchesi, Julian R Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection |
title | Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection |
title_full | Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection |
title_fullStr | Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection |
title_full_unstemmed | Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection |
title_short | Microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent Clostridioides difficile infection |
title_sort | microbial bile salt hydrolases mediate the efficacy of faecal microbiota transplant in the treatment of recurrent clostridioides difficile infection |
topic | Gut Microbiota |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839797/ https://www.ncbi.nlm.nih.gov/pubmed/30816855 http://dx.doi.org/10.1136/gutjnl-2018-317842 |
work_keys_str_mv | AT mullishbenjaminh microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT mcdonaldjulieak microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT pechlivanisalexandros microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT allegrettijessicar microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT kaodina microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT barkergracef microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT kapiladiya microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT petrofelaineo microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT joycesusana microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT gahancormacgm microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT glegolamadejskaizabela microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT williamshoracert microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT holmeselaine microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT clarkethomasb microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT thurszmarkr microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection AT marchesijulianr microbialbilesalthydrolasesmediatetheefficacyoffaecalmicrobiotatransplantinthetreatmentofrecurrentclostridioidesdifficileinfection |